108 related articles for article (PubMed ID: 3693587)
1. Predictive performance of Sawchuk-Zaske and Bayesian dosing methods for tobramycin.
Rodvold KA; Blum RA
J Clin Pharmacol; 1987; 27(5):419-24. PubMed ID: 3693587
[TBL] [Abstract][Full Text] [Related]
2. Accuracy of Bayesian and Sawchuk-Zaske dosing methods for gentamicin.
Burton ME; Chow MS; Platt DR; Day RB; Brater DC; Vasko MR
Clin Pharm; 1986 Feb; 5(2):143-9. PubMed ID: 3754192
[TBL] [Abstract][Full Text] [Related]
3. Accuracy of predicting the vancomycin concentration in Japanese cancer patients by the Sawchuk-Zaske method or Bayesian method.
Nakashima T; Ohno T; Koido K; Hashimoto H; Terakado H
J Oncol Pharm Pract; 2020 Apr; 26(3):543-548. PubMed ID: 31142231
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Sawchuk-Zaske and Bayesian forecasting for aminoglycosides in seriously ill patients.
Denaro CP; Ravenscroft PJ
Br J Clin Pharmacol; 1989 Jul; 28(1):37-44. PubMed ID: 2775614
[TBL] [Abstract][Full Text] [Related]
5. Accuracy of Bayesian, Sawchuk-Zaske, and nomogram dosing methods for vancomycin.
Garrelts JC; Godley PJ; Horton MW; Karboski JA
Clin Pharm; 1987 Oct; 6(10):795-9. PubMed ID: 3505841
[TBL] [Abstract][Full Text] [Related]
6. Monitoring of a single post-infusion blood sample to estimate the actual peak and trough concentration of tobramycin in critically ill patients.
Reimann IR; Meier-Hellmann A; Traut T; Reinhart K; Hoffmann A
Exp Toxicol Pathol; 2003 Jun; 54(5-6):493-8. PubMed ID: 12877363
[TBL] [Abstract][Full Text] [Related]
7. A Bayesian feedback method of aminoglycoside dosing.
Burton ME; Brater DC; Chen PS; Day RB; Huber PJ; Vasko MR
Clin Pharmacol Ther; 1985 Mar; 37(3):349-57. PubMed ID: 3971658
[TBL] [Abstract][Full Text] [Related]
8. Controlled comparison of gentamicin and tobramycin nephrotoxicity.
Matzke GR; Lucarotti RL; Shapiro HS
Am J Nephrol; 1983; 3(1):11-7. PubMed ID: 6340504
[TBL] [Abstract][Full Text] [Related]
9. General versus subpopulation values in Bayesian prediction of aminoglycoside pharmacokinetics in hematology-oncology patients.
Radomski KM; Davis GA; Chandler MH
Am J Health Syst Pharm; 1997 Mar; 54(5):541-4. PubMed ID: 9066862
[TBL] [Abstract][Full Text] [Related]
10. Effect of four intravenous infusion methods on tobramycin pharmacokinetics.
Pleasants RA; Sawyer WT; Williams DM; McKenna WR; Powell JR
Clin Pharm; 1988 May; 7(5):374-9. PubMed ID: 3383543
[TBL] [Abstract][Full Text] [Related]
11. Comparing dosage adjustment methods for once-daily tobramycin in paediatric and adolescent patients with cystic fibrosis.
Hennig S; Holthouse F; Staatz CE
Clin Pharmacokinet; 2015 Apr; 54(4):409-21. PubMed ID: 25403847
[TBL] [Abstract][Full Text] [Related]
12. Comparison of four methods of predicting serum gentamicin concentrations in adult patients with impaired renal function.
Platt DR; Matthews SJ; Sevka MJ; Comer JB; Quintiliani R; Cunha BA; Nightingale CH; Chow MS
Clin Pharm; 1982; 1(4):361-5. PubMed ID: 7185531
[TBL] [Abstract][Full Text] [Related]
13. Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring.
de Hoog M; Mouton JW; Schoemaker RC; Verduin CM; van den Anker JN
Clin Pharmacol Ther; 2002 May; 71(5):349-58. PubMed ID: 12011820
[TBL] [Abstract][Full Text] [Related]
14. Dosage adjustment and clinical outcomes of long-term use of high-dose tobramycin in adult cystic fibrosis patients.
Li SC; Bowes G; Ioannides-Demos LL; Spicer WJ; Hooper RE; Spelman DW; Tong N; McLean AJ
J Antimicrob Chemother; 1991 Oct; 28(4):561-8. PubMed ID: 1761450
[TBL] [Abstract][Full Text] [Related]
15. Monitoring of Tobramycin Exposure: What is the Best Estimation Method and Sampling Time for Clinical Practice?
Gao Y; Hennig S; Barras M
Clin Pharmacokinet; 2019 Mar; 58(3):389-399. PubMed ID: 30140975
[TBL] [Abstract][Full Text] [Related]
16. Bayesian Estimation of Tobramycin Exposure in Patients with Cystic Fibrosis.
Barras MA; Serisier D; Hennig S; Jess K; Norris RL
Antimicrob Agents Chemother; 2016 Nov; 60(11):6698-6702. PubMed ID: 27572411
[TBL] [Abstract][Full Text] [Related]
17. Aminoglycoside dosing in pediatric patients.
Carlstedt BC; Uaamnuichai M; Day RB; Bowman L; Brater DC
Ther Drug Monit; 1989; 11(1):38-43. PubMed ID: 2911852
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of pharmacokinetic dose determination of gentamicin in geriatric patients.
Lackner TE; Birge S
DICP; 1990 Jan; 24(1):29-32. PubMed ID: 2301187
[TBL] [Abstract][Full Text] [Related]
19. [Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].
Reimann IR; Meier-Hellmann A; Pfeifer R; Traut T; Schilling A; Stein G; Reinhart K; Hoffmann A
Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 May; 34(5):288-95. PubMed ID: 10372218
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of estimating individual pharmacokinetic data for aminoglycoside therapy in seriously ill patients.
Denaro CP; Ravenscroft PJ
Aust N Z J Med; 1987 Oct; 17(5):526-32. PubMed ID: 3446165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
